Investigation of Molecular Changes in RAS/RAF/MEK/MAPK Pathway in Serous Adenocarcinomas and Serous Borderline Tumors of Ovary

Journal Title: Journal of Ankara University Faculty of Medicine - Year 2020, Vol 73, Issue 2

Abstract

Objectives: To investigate MAP Kinase (p38), c-Fos, c-Jun and c-Myc; in RAS/RAF/MEK/MAPK pathway by immunohistochemically in high grade serous adenocarcinomas, serous borderline tumors and benign lesions of the ovary. Materials and Methods: Twelve serous borderline tumors, 41 high-grade serous carcinomas and 19 cases of serous papillary cystadenofibromas, serous cystadenomas; p38, c-Myc, c-Jun and c-Fos immunohistochemical staining were performed. Results: In borderline and benign lesions, diffuse and severe staining was observed in all cases with c-Fos, whereas focal and mild staining was observed in only 16 of the serous adenocarcinomas (p<0.05). While nuclear staining was not observed in any of the serous adenocarcinomas with c-Myc, mild and focal staining was detected in four of the borderline tumors and 16 of the benign tumors. There was a statistically significant difference in nuclear staining between the three groups (p<0.05). Nuclear staining was detected in four borderline tumors, in seven serous adenocarcinomas and in eight cases in the benign tumor group with c-Jun. These stainings were not statistically significant. Moderate staining was observed in 18 of benign tumors and in all borderline tumors and mild staining in eight of serous adenocarcinomas. A statistically significant difference was found between benign and serous borderline tumors and serous adenocarcinomas (p<0.05); there was no difference between benign tumors and borderline tumors. Conclusion: In borderline serous tumors; the nuclear expression of p38, c-Myc and c-Fos is statistically different from serous adenocarcinomas that proves the activation of the RAS/RAF/MEK/MAPK pathway in borderline tumors. In practical life, although it may seem usable in the cases that these tumors cannot be separated from serous adenocarcinoma; that we could not include in this study; the staining pattern in low-grade serous adenocarcinomas is unknown. Therefore, it should be investigated in large case series whether low grade serous adenocarcinomas and borderline tumors show similar expression patterns.

Authors and Affiliations

Cevriye Cansız Ersöz

Keywords

Related Articles

Giant Fibroadenomas in Young Women

Objectives: In this study, we consider a fibroadenoma with a size >5 cm as a giant fibroadenoma (GFA). This definition is not universally accepted but has been used in several studies. We retrospectively presented fibroa...

Morphometric Analysis of the Clivus in Human Dry Skulls: A Radioanatomical Study

Objectives: This study aims to reveal morphometric properties of the clivus including length, width and angle to the base of the skull from the perspective of skull base procedures. Materials and Methods: Twenty-four hu...

The satisfaction of Foot and Ankle Orthosis in Children with Cerebral Palsy; From the Family’s Perspective

Objectives: The aim of this study was to evaluate the compliance of ankle-foot orthosis in patients with cerebral palsy (CP) and the factors affecting compliance. Materials and Methods: The demographic data of the patie...

Management of Malignant Pleural Mesothelioma

Malignant mesothelioma (MM) arises from mesothelial surfaces of the pleural cavity, peritoneal cavity, tunica vaginalis, or pericardium. MM is a rare and insidious neoplasm with a poor prognosis. Malignant pleural mesoth...

Retrospective Evaluation of Surgically Treated Patients with Myelomeningocele

Objectives: Neural tube defects are the most common congenital malformation of the central nervous system. Identification, classification and treatment of spinal malformations are important in terms of prognosis of the n...

Download PDF file
  • EP ID EP684821
  • DOI 10.4274/atfm.galenos.2020.13007
  • Views 124
  • Downloads 0

How To Cite

Cevriye Cansız Ersöz (2020). Investigation of Molecular Changes in RAS/RAF/MEK/MAPK Pathway in Serous Adenocarcinomas and Serous Borderline Tumors of Ovary. Journal of Ankara University Faculty of Medicine, 73(2), -. https://europub.co.uk/articles/-A-684821